Medicine News and Research

RSS

Oxford launches LEGACY03 trial to unravel age-related vaccine mysteries

Vaccines are the most effective way to prevent infectious diseases (NHS, 2023) however, people respond to them in different ways.

18 Jan 2024

Machine learning algorithm decodes mutations driving cancer treatment resistance

In a groundbreaking study published on January 18, 2024, in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one of the biggest challenges facing cancer researchers: predicting when cancer will resist chemotherapy.

18 Jan 2024

St. Jude announces $13 million investment to expand the understanding of G-protein coupled receptors

St. Jude Children's Research Hospital today announced a nearly $13 million investment toward a new research collaboration with scientists at Columbia University, Duke University and Stanford University to expand the understanding of G-protein coupled receptors (GPCR), which are vital proteins that impact human health and disease.

18 Jan 2024

ARCHA at Aston University secures £400,000 to recruit four PhD students for dementia research

The Aston Research Centre for Health in Ageing (ARCHA) at Aston University has received £400,000 in funding to recruit four PhD students for a dementia research programme.

18 Jan 2024

Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a Phase I/II trial of 37 patients with relapsed or refractory B-cell malignancies who were treated with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy targeting CD19.

18 Jan 2024

Understanding antimicrobial resistance in hospital-acquired pneumonia

New research has been published that identifies positive steps towards a better understanding of antimicrobial resistance (AMR), specifically in hospital-acquired pneumonia (HAP).

18 Jan 2024

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

The efficacy of the controlled release of low-dose morphine as treatment against that of a placebo in idiopathic pulmonary fibrosis.

18 Jan 2024

Combined effect of poverty and inflammation on mortality is worse than expected from separate effects, study reports

Researchers investigated whether the combination of chronic inflammation and poverty synergistically increases the 15-year risk of mortality from all causes, heart disease, and cancer in American adults aged 40 and older.

18 Jan 2024

Short strands of toxic RNAs contribute to brain cell death and DNA damage in Alzheimer's

Alzheimer's disease, which is expected to have affected about 6.7 million patients in the U.S. in 2023, results in a substantial loss of brain cells.

18 Jan 2024

Play to prevent: Video games for preventing falls in community-dwelling older people

Researchers evaluated the effectiveness of home-based cognitive and exergame step training interventions compared with a control group in preventing falls among community-dwelling older adults.

18 Jan 2024

‘Emergency’ or not, covid is still killing people. Here’s what doctors advise to stay safe.

With around 20,000 people dying of covid in the United States since the start of October, and tens of thousands more abroad, the covid pandemic clearly isn't over.

18 Jan 2024

Women and minorities bear the brunt of medical misdiagnosis

Charity Watkins sensed something was deeply wrong when she experienced exhaustion after her daughter was born.

18 Jan 2024

New bioengineered strategy shows potential for treating ulcerative colitis

By taking advantage of mechanisms that allow cancer cells to evade immune attack, UT Southwestern Medical Center researchers have developed a new strategy in animal models that has potential for treating ulcerative colitis.

17 Jan 2024

OCD patients may have higher risk of death from both natural and unnatural causes

People with obsessive-compulsive disorder (OCD) may have an increased risk of death from both natural and unnatural causes than those without the disorder, finds a study from Sweden published by The BMJ today.

17 Jan 2024

ALS progression linked to mitochondria-associated membrane-ER disconnection

Researchers at Nagoya University in Japan have discovered a relationship between the progression of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and the disruption of mitochondria-associated membranes (MAM), the contact point between the mitochondria and the endoplasmic reticulum (ER) of the cell.

17 Jan 2024

Medicine News and Research

Oxford launches LEGACY03 trial to unravel age-related vaccine mysteries

Machine learning algorithm decodes mutations driving cancer treatment resistance

St. Jude announces $13 million investment to expand the understanding of G-protein coupled receptors

ARCHA at Aston University secures £400,000 to recruit four PhD students for dementia research

Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Understanding antimicrobial resistance in hospital-acquired pneumonia

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

Combined effect of poverty and inflammation on mortality is worse than expected from separate effects, study reports

Short strands of toxic RNAs contribute to brain cell death and DNA damage in Alzheimer's

Play to prevent: Video games for preventing falls in community-dwelling older people

‘Emergency’ or not, covid is still killing people. Here’s what doctors advise to stay safe.

Women and minorities bear the brunt of medical misdiagnosis

New bioengineered strategy shows potential for treating ulcerative colitis

OCD patients may have higher risk of death from both natural and unnatural causes

ALS progression linked to mitochondria-associated membrane-ER disconnection

New vaccine turns preexisting flu immunity into COVID-19 weapon

Innovative computational tool unearths hidden cancer targets for immunotherapy

Monkey study points to HIV vulnerability for vaccine attack

RBMX protein emerges as key player in cancer progression and immunotherapy response

Study: Breast cancer deaths continue to drop as treatments improve

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News